262 related articles for article (PubMed ID: 22319577)
21. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
[TBL] [Abstract][Full Text] [Related]
22. Combination of CTL-associated antigen-4 blockade and depletion of CD25 regulatory T cells enhance tumour immunity of dendritic cell-based vaccine in a mouse model of colon cancer.
Saha A; Chatterjee SK
Scand J Immunol; 2010 Feb; 71(2):70-82. PubMed ID: 20384858
[TBL] [Abstract][Full Text] [Related]
23. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
25. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.
Yamaguchi T; Hirota K; Nagahama K; Ohkawa K; Takahashi T; Nomura T; Sakaguchi S
Immunity; 2007 Jul; 27(1):145-59. PubMed ID: 17613255
[TBL] [Abstract][Full Text] [Related]
26. NY-ESO-1-specific circulating CD4+ T cells in ovarian cancer patients are prevalently T(H)1 type cells undetectable in the CD25+ FOXP3+ Treg compartment.
Redjimi N; Duperrier-Amouriaux K; Raimbaud I; Luescher I; Dojcinovic D; Classe JM; Berton-Rigaud D; Frenel JS; Bourbouloux E; Valmori D; Ayyoub M
PLoS One; 2011; 6(7):e22845. PubMed ID: 21829534
[TBL] [Abstract][Full Text] [Related]
27. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
28. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
Li L; Lao SH; Wu CY
Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
[TBL] [Abstract][Full Text] [Related]
29. Human Mucosa-Associated Invariant T Cells Accumulate in Colon Adenocarcinomas but Produce Reduced Amounts of IFN-γ.
Sundström P; Ahlmanner F; Akéus P; Sundquist M; Alsén S; Yrlid U; Börjesson L; Sjöling Å; Gustavsson B; Wong SB; Quiding-Järbrink M
J Immunol; 2015 Oct; 195(7):3472-81. PubMed ID: 26297765
[TBL] [Abstract][Full Text] [Related]
30. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
[TBL] [Abstract][Full Text] [Related]
31. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans.
Cavassani KA; Campanelli AP; Moreira AP; Vancim JO; Vitali LH; Mamede RC; Martinez R; Silva JS
J Immunol; 2006 Nov; 177(9):5811-8. PubMed ID: 17056505
[TBL] [Abstract][Full Text] [Related]
32. CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity.
Redjimi N; Raffin C; Raimbaud I; Pignon P; Matsuzaki J; Odunsi K; Valmori D; Ayyoub M
Cancer Res; 2012 Sep; 72(17):4351-60. PubMed ID: 22798340
[TBL] [Abstract][Full Text] [Related]
33. Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener's granulomatosis.
Klapa S; Mueller A; Csernok E; Fagin U; Klenerman P; Holl-Ulrich K; Gross WL; Lamprecht P
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):72-80. PubMed ID: 20412707
[TBL] [Abstract][Full Text] [Related]
34. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
35. Ethyl Pyruvate Stimulates Regulatory T Cells and Ameliorates Type 1 Diabetes Development in Mice.
Koprivica I; Vujičić M; Gajić D; Saksida T; Stojanović I
Front Immunol; 2018; 9():3130. PubMed ID: 30687329
[TBL] [Abstract][Full Text] [Related]
36. CD25-expressing Th17 cells mediate CD8
Lang C; Wang J; Chen L
Exp Cell Res; 2017 Nov; 360(2):384-389. PubMed ID: 28942020
[TBL] [Abstract][Full Text] [Related]
37. Behavior of circulating CD4+CD25+Foxp3+ regulatory T cells in colon cancer patients undergoing surgery.
Sellitto A; Galizia G; De Fanis U; Lieto E; Zamboli A; Orditura M; De Vita F; Giunta R; Lucivero G; Romano C
J Clin Immunol; 2011 Dec; 31(6):1095-104. PubMed ID: 21915633
[TBL] [Abstract][Full Text] [Related]
38. Activation and Recruitment of Regulatory T Cells via Chemokine Receptor Activation in Trichinella spiralis-Infected Mice.
Ahn JB; Kang SA; Kim DH; Yu HS
Korean J Parasitol; 2016 Apr; 54(2):163-71. PubMed ID: 27180574
[TBL] [Abstract][Full Text] [Related]
39. Induction of T regulatory cells by cytotoxic T-lymphocyte antigen-2α on corneal endothelial cells.
Sugita S; Yamada Y; Horie S; Nakamura O; Ishidoh K; Yamamoto Y; Yamagami S; Mochizuki M
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2598-605. PubMed ID: 21245393
[TBL] [Abstract][Full Text] [Related]
40. Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer.
Lin YC; Mahalingam J; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Chiu CT; Lin CY
Int J Cancer; 2013 Mar; 132(6):1341-50. PubMed ID: 22907255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
